Nimet Aktaş

Nimet Aktaş

Auto-generated profile, based on publicly available information

Nimet Aktaş

University of Health Sciences, Bursa Yuksek lhtisas Training and Research Hospital, Department of Nephrology, Bursa, Türkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2019 in The European Research Journal
Verified
Journal Article
Open access
SESelin Akturk Esen
Selin Akturk Esen
SKSerdar Kahvecioglu
Serdar Kahvecioglu
CGCuma Bulent Gul
Cuma Bulent Gul
NANimet Aktaş
Nimet Aktaş
IEirfan Esen
irfan Esen
Herbal medicines are believed to be effective in the treatment of many diseases. The genius Teucrium is a member of Lamiaceae family, which contains more than 300 species. Antimutagenic, anticancer, hypoglycemic, antibacterial, anti-inflammatory, antipyretic, antiulcer, hypolipidemic and antidiarrheal effects of Teucrium polium have been reported in the studies. In this article, we describe an acute kidney injury (AKI), which is thought to have developed as a result of T. polium use for the treatment of diabetes mellitus. It should not be forgotten that herbal medicine is an important reason for AKI. In addition, community should be made aware of the danger of herbal medicines which especially have potential renal and hepatic side effects.

1 September 2026 in The European Research Journal
Verified
Journal Article
Open access
PDF file
NSNazife Nur Özer Sensoy
Nazife Nur Özer Sensoy
SSSevil Sadri
Sevil Sadri
YAYavuz - AYAR
Yavuz - AYAR
TETürker EMRE
Türker EMRE
ÖGÖzgür Ömer Gül
Özgür Ömer Gül
MUMehmet Usta
Mehmet Usta
Objective: The hemoglobin–albumin–lymphocyte–platelet (HALP) score reflects nutritional-inflammatory status and is a prognostic marker in several malignancies. Its potential association with renal recovery in newly diagnosed multiple myeloma (MM) remains unclear. We investigated the relationship between baseline HALP score and renal recovery in patients with newly diagnosed MM. Methods: We retrospectively evaluated 133 consecutive patients with newly diagnosed MM. Renal response analyses were restricted to 56 patients meeting prespecified baseline eGFR criteria. Renal recovery was defined by modified International Myeloma Working Group (IMWG) criteria using the last available follow-up eGFR. The median follow-up was 15 months (interquartile range [IQR], 6.5-20.75). The HALP score was evaluated using group comparisons, receiver operating characteristic (ROC), correlation, and logistic regression analyses. Results: In the renal outcome cohort (n = 56), 37 (66.1%) achieved renal recovery and 19 (33.9%) experienced nonrecovery. The median HALP score did not differ significantly between the recovery and nonrecovery groups (27.66 [IQR, 20.85–45.95] vs 22.82 [IQR, 9.90–54.94]; P = .364). HALP score discrimination for renal recovery was limited (area under the curve [AUC], 0.575; 95% CI, 0.435–0.706; P = .422). An exploratory cutoff of >18.91 yielded a sensitivity of 81.1% and specificity of 47.4%. HALP ≥18.91 was not significantly associated with renal recovery in univariable analysis (odds ratio [OR], 3.12; 95% CI, 0.91–10.64; P = .069) but showed a significant association after multivariable adjustment (OR, 4.32; 95% CI, 1.13–16.58; P = .033). The HALP score did not correlate with ΔeGFR (r = −0.058; P = .671). Conclusions: The continuous HALP score showed limited discrimination for renal recovery. However, an exploratory threshold of ≥18.91 was associated with recovery after multivariable adjustment. Given the modest sample size, wide CI, and nonsignificant ROC analysis, this threshold-based finding requires confirmation in larger independent cohorts.

22 July 2026 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
NANimet Aktaş
Nimet Aktaş
MAMustafa Özgür Akça
Mustafa Özgür Akça
SKSabiha Kömoğlu
Sabiha Kömoğlu
NBNurhan Bilen
Nurhan Bilen
HOHATİCE ORTAC
HATİCE ORTAC
Objective: Differences in peritoneal dialysis (PD)-associated peritonitis rates worldwide may be due to differences in definitions as well as differences in practice and risk factors. We aimed to present our center data and to reveal our peritonitis characteristics and risk factors with literature recommendations. Materials and Methods: Total of 92 peritonitis episodes that developed in 51 (34,22%) of 149 patients receiving PD treatment between January 2009 - 2021 in our unit were retrospectively evaluated. During the follow-up period, peritonitis frequency, culture (-) peritonitis, peritonitis-free-patient, hospitalization due to peritonitis, transition to permanent hemodialysis (HD), peritonitis occurring after PD catheter insertion and prior to commencement of PD treatment (Pre-PD peritonitis), mortality rates were calculated on annual basis and peritoneal fluid culture growths were evaluated. In addition, peritonitis risk factors were analyzed in all patients who received PD treatment during this period. Results: In our center over the years, the frequency of peritonitis was maximum (max) 0.38 episodes/patient year, culture (-) peritonitis max: 75%, peritonitis-free patients max: 98%, hospitalization due to peritonitis max: 75%, permanent HD transition max: 50%, Pre-PD peritonitis max: 9%, no mortality due to peritonitis was observed. Gram (Gr) + bacteria were found in 68.4% (n=39) of peritoneal fluid cultures. Daily urine volume (p=0.02), serum albumin (p=0.02), potassium (p=0.02) and hemoglobin levels (p=0.01) were lower in the group with peritonitis compared to the group with out peritonitis. Conclusion: Regular evaluation of the peritonitis characteristics of each center determines the need to revise the practices of the centers. Additionally, awareness of peritonitis risk factors will contribute to the improvement of peritonitis rates by enabling the implementation of necessary interventions in this regard.

15 September 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NANimet Aktas
Nimet Aktas
AEAlparslan Ersoy
Alparslan Ersoy
AOAysegul Oruc
Aysegul Oruc
HOHatice Ortac
Hatice Ortac
Background: The COVID-19 pandemic caused major disruptions in solid organ transplantation worldwide, particularly in kidney transplantation. Patients on deceased-donor kidney transplant waiting lists represent a vulnerable population due to ongoing dialysis requirements and concerns regarding immunosuppression and infection risk. Objective: This study aimed to evaluate the attitudes, behaviors, and concerns of patients on the deceased-donor kidney transplant waiting list regarding kidney transplantation during the second wave of the COVID-19 pandemic. Methods: A cross-sectional, telephone-based survey was conducted between October and December 2020 at one tertiary care centre in Turkiye. The survey assessed adherence to preventive measures, COVID-19 exposure history, perceptions of renal replacement therapy modalities, attitudes toward kidney transplantation, and transplantation-related concerns during the pandemic. Demographic and clinical data were collected, and responses were analyzed using appropriate statistical methods. Results: A total of 188 transplant candidates (mean age 47.3 ± 13.1 years; 56.4% male) were included. Adherence to preventive measures was reported by 99.5% of participants, and 80.9% followed quarantine rules. Although 76% of participants preferred kidney transplantation before the pandemic, this rate decreased to 55.3% during the pandemic. Despite this decline, 86.7% of participants stated that they would accept a deceased-donor kidney transplant if offered during the pandemic. Only 38.3% reported concerns about undergoing transplantation, with the most common concerns being infection risk related to immunosuppressive therapy, hospital-acquired COVID-19, and donor-related transmission. Shorter renal replacement therapy duration and preemptive transplant status were associated with more favorable attitudes toward transplantation during the pandemic. Conclusions: Despite pandemic-related uncertainties and concerns, most patients on the deceased-donor kidney transplant waiting list demonstrated a willingness to proceed with kidney transplantation and showed high adherence to preventive measures. These findings highlight the importance of patient education, infection-control strategies, and transparent communication to ensure the sustainability of kidney transplant programs during current and future pandemics.

22 October 2026 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
NANimet Aktaş
Nimet Aktaş
SKSerdar Kahvecioglu
Serdar Kahvecioglu
HOHATİCE ORTAC
HATİCE ORTAC
HOHaluk Barbaros Oral
Haluk Barbaros Oral
MKMert Karaca
Mert Karaca
HCHuseyin Celik
Huseyin Celik
Panel-reactive antibody (PRA) is an established marker of pre-transplant immunological sensitization; however, the relationship between PRA positivity and routinely measured platelet indices remains unclear. The present retrospective observational study investigated the association between PRA positivity and platelet count, as well as indices, in adult kidney transplant candidates. Following the screening of 450 candidates, 208 were deemed eligible after excluding patients with active infection, those using medications affecting platelet indices, or those for whom simultaneous PRA and complete blood count measurements were unavailable. The demographic, laboratory, and immunological data of all participants were recorded. Of these, 58 (27.9%) were classified as PRA-positive (PRA >10%) and 150 (72.1%) as PRA-negative (PRA ≤10%). The cohort comprised 114 women (54.8%) and 94 men (45.2%). Compared with PRA-negative patients, PRA-positive patients had a higher proportion of women (77.6% vs. 46.0%; p < 0.001), longer median dialysis duration (51.5 [28.5–85.0] vs. 26.0 [2.75–50.25] months; p < 0.001), and higher median platelet distribution width (PDW; 16.45 [16.07–16.90] vs. 16.20 [15.80–16.60] fL; p = 0.006). However, platelet count, mean platelet volume, and plateletcrit were comparable. In multivariable analysis, female sex, longer dialysis duration, peritoneal dialysis, and higher PDW values were independently associated with PRA positivity, although the absolute difference between the PRA-positive and PRA-negative groups was small (16.45 vs. 16.20 fL). Higher PDW was associated with PRA positivity in kidney transplant candidates; however, the small between-group difference and the observational design preclude conclusions regarding its clinical utility. Further prospective studies are required to confirm this association.